Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results.

Brown J, Kumar K, Reading J, Harvey J, Murthy S, Capocci S, Hopkins S, Seneviratne S, Cropley I, Lipman M.

Eur Respir J. 2017 Oct 26;50(4). pii: 1701267. doi: 10.1183/13993003.01267-2017. Print 2017 Oct. No abstract available.

2.

Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.

Brown J, McGowan JA, Chouial H, Capocci S, Smith C, Ivens D, Johnson M, Sathia L, Shah R, Lampe FC, Rodger A, Lipman M.

HIV Med. 2017 Sep;18(8):604-612. doi: 10.1111/hiv.12497. Epub 2017 Mar 13.

PMID:
28294498
3.

Influenza immunisation: knowledge and actions taken by UK HIV-positive adults.

Ellis J, Brown J, Smith C, Snell L, Capocci S, Ferro F, Ferreira J, Marshall N, Webster D, Johnson M, Lipman M.

HIV Med. 2016 May;17(5):397-9. doi: 10.1111/hiv.12309. Epub 2015 Sep 3. No abstract available.

4.

Airway bacteria and respiratory symptoms are common in ambulatory HIV-positive UK adults.

Nimmo C, Capocci S, Honeyborne I, Brown J, Sewell J, Thurston S, Johnson M, McHugh TD, Lipman M.

Eur Respir J. 2015 Oct;46(4):1208-11. doi: 10.1183/13993003.00361-2015. Epub 2015 Jun 25. No abstract available.

5.

Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area.

Capocci S, Smith C, Morris S, Bhagani S, Cropley I, Abubakar I, Johnson M, Lipman M.

Eur Respir J. 2015 Jul;46(1):165-74. doi: 10.1183/09031936.00067114. Epub 2015 Apr 16.

6.

Health status and quality of life in tuberculosis.

Brown J, Capocci S, Smith C, Morris S, Abubakar I, Lipman M.

Int J Infect Dis. 2015 Mar;32:68-75. doi: 10.1016/j.ijid.2014.12.045. Review.

7.

Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysis.

Sewell J, Capocci S, Johnson J, Solamalai A, Hopkins S, Cropley I, Webster DP, Lipman M.

J Infect. 2015 Apr;70(4):317-23. doi: 10.1016/j.jinf.2014.10.014. Epub 2014 Nov 5.

PMID:
25452045
8.

Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?

Melchionda V, Wyatt H, Capocci S, Garcia Medina R, Solamalai A, Katiri S, Hopkins S, Cropley I, Lipman M.

Eur Respir J. 2013 Oct;42(4):1148-50. doi: 10.1183/09031936.00184312. No abstract available.

9.

Impact of hepatitis B-active combination antiretroviral therapy on hepatitis B susceptibility in newly diagnosed HIV patients.

Calisti G, Capocci SJ, Ware A, Dudill R, Smith C, Johnson MA, Lipman MC, Webster DP.

Clin Infect Dis. 2014 Jan;58(1):137-9. doi: 10.1093/cid/cit607. Epub 2013 Sep 17. No abstract available.

PMID:
24046299
10.

The value of "inform and advise" guidance in a case of extensive tuberculosis transmission.

Kumar K, Shorten RJ, Capocci S, Solamalai A, Goodburn A, Cropley I, McHugh TD, Lipman M.

J Infect. 2013 Aug;67(2):158-60. doi: 10.1016/j.jinf.2013.04.005. Epub 2013 Apr 13. No abstract available.

PMID:
23588105
11.

Respiratory infections in HIV-infected adults: epidemiology, clinical features, diagnosis and treatment.

Capocci S, Lipman M.

Curr Opin Pulm Med. 2013 May;19(3):238-43. doi: 10.1097/MCP.0b013e32835f1b5c. Review.

PMID:
23422413
12.

Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNF╬▒ therapy.

Greveson K, Goodhand J, Capocci S, Woodward S, Murray C, Cropley I, Hamilton M, Lipman M.

J Crohns Colitis. 2013 Jun;7(5):412-8. doi: 10.1016/j.crohns.2012.08.010. Epub 2012 Sep 24.

PMID:
23009739

Supplemental Content

Loading ...
Support Center